Related references
Note: Only part of the references are listed.Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
Alexandra Schafer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Proinflammatory IgG Fc structures in patients with severe COVID-19
Saborni Chakraborty et al.
NATURE IMMUNOLOGY (2021)
Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination
Carolyn M. Boudreau et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Reassessing therapeutic antibodies for neglected and tropical diseases
Rob Hooft van Huijsduijnen et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples
Alessandro Manenti et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
Zou Xin et al.
FRONTIERS OF MEDICINE (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Sin Fun Sia et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Developing therapeutic monoclonal antibodies at pandemic pace
Brian Kelley
NATURE BIOTECHNOLOGY (2020)
A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
Maria Romano et al.
CELLS (2020)
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
Wafaa B. Alsoussi et al.
JOURNAL OF IMMUNOLOGY (2020)
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
Jakob Kreye et al.
CELL (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
Naoki Kaneko et al.
CELL (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Ann M. Arvin et al.
NATURE (2020)
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Seth J. Zost et al.
NATURE MEDICINE (2020)
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
M. Pamela Griffin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Masaki Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh et al.
SCIENCE (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Structural basis of a shared antibody response to SARS-CoV-2
Meng Yuan et al.
SCIENCE (2020)
The COVID-19 Pandemic and the $16 Trillion Virus
David M. Cutler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
Alina Baum et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Dried SARS-CoV-2 virus maintains infectivity to Vero E6 cells for up to 48 h
Hyesun Jang et al.
VETERINARY MICROBIOLOGY (2020)
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Wen Shi Lee et al.
NATURE MICROBIOLOGY (2020)
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
Yu Zuo et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis
Christina B. Karsten et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life
Brian C. Mackness et al.
MABS (2019)
INFECTIOUS DISEASES Successful Ebola treatments promise to tame outbreak
Kai Kupferschmidt
SCIENCE (2019)
A Sample-Sparing Multiplexed ADCP Assay
Audrey L. Butler et al.
FRONTIERS IN IMMUNOLOGY (2019)
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults
Martin R. Gaudinski et al.
PLOS MEDICINE (2018)
Use of broadly neutralizing antibodies for HIV-1 prevention
Amarendra Pegu et al.
IMMUNOLOGICAL REVIEWS (2017)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
Tilman Schlothauer et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
Margaret E. Ackerman et al.
PLOS PATHOGENS (2016)
Pseudotype-based neutralization on assays for influenza: a systematic analysis
George William Carnell et al.
FRONTIERS IN IMMUNOLOGY (2015)
An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
K. Grehan et al.
METHODSX (2015)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for FcγR2a and FcγR2b
Margaret E. Ackerman et al.
JOURNAL OF VIROLOGY (2013)
Isolation of human monoclonal antibodies from peripheral blood B cells
Jinghe Huang et al.
NATURE PROTOCOLS (2013)
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Sjors H. W. Scheres
JOURNAL OF STRUCTURAL BIOLOGY (2012)
Enhanced antibody half-life improves in vivo activity
Jonathan Zalevsky et al.
NATURE BIOTECHNOLOGY (2010)
Appion: An integrated, database-driven pipeline to facilitate EM image processing
Gabriel C. Lander et al.
JOURNAL OF STRUCTURAL BIOLOGY (2009)
DoG Picker and TiltPicker: Software tools to facilitate particle selection in single particle electron microscopy
N. R. Voss et al.
JOURNAL OF STRUCTURAL BIOLOGY (2009)
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
Thomas Tiller et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Automated molecular microscopy: The new Leginon system
C Suloway et al.
JOURNAL OF STRUCTURAL BIOLOGY (2005)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Share Paper
